Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y006122 | — |
no symptomatic AE; an adult patient received a pediatric dose of VAQTA instead of an adult dose; This spontaneous report was received from a nurse and refers to a 22-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 25-JAN-2025, the patient was vaccinated with Hepatitis A Vaccine, Inactivated (VAQTA) suspension for injection, 0.5 ml, administered for prophylaxis by a health professional (lot #Y006122, expiration date: 17-MAY-2025; strength and route were not reported). The adult patient received a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) instead of an adult dose (Incorrect dose administered). No symptomatic adverse event (AE) was reported.